一个增强的三阶段设计与对过敏原免疫疗法试验的趋势分析
Xinyu Tang1, Ronald L Rabin2, Lihan K Yan1
1Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA), Silver Spring, MD, United States of America.
PloS one
|September 14, 2023
概括
本研究引入了一种趋势分析,以更好地评估过敏原免疫疗法 (AIT) 随着时间的推移的影响,补充现有方法. 这种新方法增强了对研究期以外持续治疗的益处的理解.
科学领域:
- 免疫学 免疫学 免疫学
- 临床试验 临床试验
- 生物统计学 生物统计学
背景情况:
- 过敏原免疫疗法 (AIT) 试验传统上使用末期分析.
- 由于不同阶段的持续时间,阶段结束的差异可能无法完全捕捉治疗效果.
- 对AIT的全面评估需要在整个研究期间评估治疗反应.
研究的目的:
- 引入和评估AIT试验的新趋势分析.
- 通过结合趋势分析来增强AIT三阶段试验设计.
- 评估治疗效益的持续性和对AIT的持续反应.
主要方法:
- 开发了额外的趋势分析,以评估整个阶段的进展曲线差异.
- 在一个增强的三阶段AIT设计中,结合了阶段结束和趋势分析.
- 进行模拟研究以评估不同条件下的趋势分析的统计性质 (偏差,功率).
主要成果:
- 趋势分析提供了研究期以外阶段性影响的证据.
- 模拟结果显示,偏差取决于缺失的数据机制和效果大小.
- 功率受到效应大小,样本大小和成功率的影响,特别是相对趋势.
结论:
- 趋势分析补充了阶段结束分析,加强了AIT中阶段性影响的说法.
- 拟议的趋势分析支持评估AIT随时间推移所带来的好处.
- 这种统计方法可以为AIT治疗的临床理解和决策提供信息.
更多相关视频
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
10.1K
03:40Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
547
相关概念视频
02:06Allergic Reactions
27.7K
Overview
27.7K
01:16Crossover Experiments
2.9K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.9K